Clinical Practice. Primary Ovarian Insufficiency

Overview

Journal N Engl J Med

Specialty General Medicine

Date 2009 Feb 7

PMID 19196677

Citations 400

Authors

Lawrence M Nelson

Affiliations

Soon will be listed here.

Citing Articles

The Functions and Implications of MicroRNAs in Premature Ovarian Insufficiency.

Gao H, Cao X, Hua H, Zhu H Mol Genet Genomic Med. 2025; 13(2):e70074.

PMID: 39959946 PMC: 11831191. DOI: 10.1002/mgg3.70074.

Physical activity associated with age at menopause: A Mendelian randomization study.

Sun X Medicine (Baltimore). 2025; 104(6):e41514.

PMID: 39928759 PMC: 11813050. DOI: 10.1097/MD.0000000000041514.

Female Oncofertility and Immune Checkpoint Blockade in Melanoma: Where Are We Today?.

Lee C, Martinez E, Malon Gimenez D, Muniz T, Butler M, Saibil S Cancers (Basel). 2025; 17(2).

PMID: 39858020 PMC: 11763405. DOI: 10.3390/cancers17020238.

Improvement of ovarian function in a premature ovarian failure mouse model using Vitex agnus-castus extract.

Soleimany Z, Siadat F, Farhadi M, Mirshaby Z, Sanadgol Z, Eyni H JBRA Assist Reprod. 2025; 29(1):117-126.

PMID: 39835794 PMC: 11867258. DOI: 10.5935/1518-0557.20240101.

Transcriptional Integration of Meiotic Prophase I Progression and Early Oocyte Differentiation.

Abt K, Bartholomew M, Nixon A, Richman H, Gura M, Seymour K bioRxiv. 2025; .

PMID: 39829852 PMC: 11741336. DOI: 10.1101/2025.01.06.631470.

References

Gibbons W, MOYER D, Lobo R, Roy S, Mishell Jr D . Biochemical and histologic effects of sequential estrogen/progestin therapy on the endometrium of postmenopausal women. Am J Obstet Gynecol. 1986; 154(2):456-61. DOI: 10.1016/0002-9378(86)90690-3. View

Stazi A, Mantovani A . A risk factor for female fertility and pregnancy: celiac disease. Gynecol Endocrinol. 2001; 14(6):454-63. DOI: 10.3109/09513590009167719. View

Scarabin P, Oger E, Plu-Bureau G . Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. Lancet. 2003; 362(9382):428-32. DOI: 10.1016/S0140-6736(03)14066-4. View

Gallagher J . Effect of early menopause on bone mineral density and fractures. Menopause. 2007; 14(3 Pt 2):567-71. DOI: 10.1097/gme.0b013e31804c793d. View

Alper M, Jolly E, Garner P . Pregnancies after premature ovarian failure. Obstet Gynecol. 1986; 67(3 Suppl):59S-62S. DOI: 10.1097/00006250-198603001-00018. View

Martyn-St James M, Carroll S . A meta-analysis of impact exercise on postmenopausal bone loss: the case for mixed loading exercise programmes. Br J Sports Med. 2008; 43(12):898-908. DOI: 10.1136/bjsm.2008.052704. View

Bakalov V, Anasti J, Calis K, Vanderhoof V, Premkumar A, Chen S . Autoimmune oophoritis as a mechanism of follicular dysfunction in women with 46,XX spontaneous premature ovarian failure. Fertil Steril. 2005; 84(4):958-65. DOI: 10.1016/j.fertnstert.2005.04.060. View

. Current evaluation of amenorrhea. Fertil Steril. 2004; 82 Suppl 1:S33-9. DOI: 10.1016/j.fertnstert.2004.07.001. View

de Kleijn M, van der Schouw Y, Verbeek A, Peeters P, Banga J, van der Graaf Y . Endogenous estrogen exposure and cardiovascular mortality risk in postmenopausal women. Am J Epidemiol. 2002; 155(4):339-45. DOI: 10.1093/aje/155.4.339. View

10.

Coulam C, Adamson S, Annegers J . Incidence of premature ovarian failure. Obstet Gynecol. 1986; 67(4):604-6. View

11.

Sherman S, Pletcher B, Driscoll D . Fragile X syndrome: diagnostic and carrier testing. Genet Med. 2005; 7(8):584-7. PMC: 3110946. DOI: 10.1097/01.gim.0000182468.22666.dd. View

12.

Rebar R, CONNOLLY H . Clinical features of young women with hypergonadotropic amenorrhea. Fertil Steril. 1990; 53(5):804-10. View

13.

van Kasteren Y, Hundscheid R, SMITS A, Cremers F, van Zonneveld P, Braat D . Familial idiopathic premature ovarian failure: an overrated and underestimated genetic disease?. Hum Reprod. 1999; 14(10):2455-9. DOI: 10.1093/humrep/14.10.2455. View

14.

. ACOG committee opinion. No. 338: Screening for fragile X syndrome. Obstet Gynecol. 2006; 107(6):1483-5. DOI: 10.1097/00006250-200606000-00059. View

15.

Drake M, Clarke B, Khosla S . Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc. 2008; 83(9):1032-45. PMC: 2667901. DOI: 10.4065/83.9.1032. View

16.

Bjarnason K, Cerin A, Lindgren R, Weber T . Adverse endometrial effects during long cycle hormone replacement therapy. Scandinavian Long Cycle Study Group. Maturitas. 1999; 32(3):161-70. DOI: 10.1016/s0378-5122(99)00033-x. View

17.

Welt C, Smith P, Taylor A . Evidence of early ovarian aging in fragile X premutation carriers. J Clin Endocrinol Metab. 2004; 89(9):4569-74. DOI: 10.1210/jc.2004-0347. View

18.

Nelson L, Kimzey L, White B, Merriam G . Gonadotropin suppression for the treatment of karyotypically normal spontaneous premature ovarian failure: a controlled trial. Fertil Steril. 1992; 57(1):50-5. DOI: 10.1016/s0015-0282(16)54775-x. View

19.

Wittenberger M, Hagerman R, Sherman S, McConkie-Rosell A, Welt C, Rebar R . The FMR1 premutation and reproduction. Fertil Steril. 2006; 87(3):456-65. DOI: 10.1016/j.fertnstert.2006.09.004. View

20.

Greil A . Infertility and psychological distress: a critical review of the literature. Soc Sci Med. 1998; 45(11):1679-704. DOI: 10.1016/s0277-9536(97)00102-0. View